For following the competition: what moved in each program, several studies read as one move.
- MDSY-1240
- GGTI-2418
- Anti-CD70/CD3 Bispecific Antibody INCA036873
- + 3 more
Mondays · ranked, phase 3 first · readouts ahead · See a sample brief
Add Lymphoma, T-Cell, Cutaneous to watchlistEvery Monday by email · turn it off any timePro · free during the beta